High-flow nasal cannula oxygen therapy for asthma exacerbation
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the clinical effectiveness and safety of high-flow nasal cannula (HFNC) oxygen therapy compared with conventional oxygen therapy for the management of asthma exacerbations in children and adults. We will also explore potential equity implications, including differences in access to and outcomes of HFNC oxygen therapy across diverse healthcare settings and populations.
Authors
- Takanori Imai (ORCID: https://orcid.org/0000-0002-6003-4996)
- Takeshi Hasegawa (ORCID: https://orcid.org/0000-0001-9581-4442)
- Yoshifusa Abe (ORCID: https://orcid.org/0000-0002-4861-8200)
- Edward F. Barroga (ORCID: https://orcid.org/0000-0002-8920-2607)
- Erika Ota (ORCID: https://orcid.org/0000-0002-3945-7441)
- Aiko Honda (ORCID: https://orcid.org/0000-0001-7959-4320)
- Yoshitaka Watanabe (ORCID: https://orcid.org/0000-0003-3852-5219)
- Noyuri Yamaji (ORCID: https://orcid.org/0000-0002-4212-6723)
- Hisashi Noma (ORCID: https://orcid.org/0000-0002-2520-9949)
- Sojiro Kusumoto
Institutions
- SHOWA Medical University (JP)
- St. Luke's International University (JP)
- SHOWA Medical University Northern Yokohama Hospital (JP)
- University of Tokyo Health Sciences (JP)
- The Institute of Statistical Mathematics (JP)
- SHOWA Medical University Hospital (JP)
Publication Details
- Journal
- Cochrane Database of Systematic Reviews
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1002/14651858.cd016205
- Primary Topic
- Respiratory Support and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00